Acticor Biotech
is a biopharmaceutical company that develops monoclonal antibody therapeutics for the treatment of thrombo-embolic diseases... Read moreActicor Biotech
is a biopharmaceutical company that develops monoclonal antibody therapeutics for the treatment of thrombo-embolic diseases... Read more
News
Jan 06, 2025
FinanzNachrichten
Acticor Biotech: Acticor Biotech announces its liquidation proceedings
Dec 19, 2024
Marketscreener
Acticor Biotech: Acticor Biotech Announces that the Court Judgment Has Been Postponed Until January 2, 2025
Dec 10, 2024
FinanzNachrichten
Acticor Biotech: Acticor Biotech Announces the Filing of a Request for Conversion of Receivership Proceedings Into Liquidation Proceedings
Nov 06, 2024
FinanzNachrichten
Acticor Biotech: Acticor Biotech Provides an Update on the Current Receivership Proceedings
Nov 04, 2024
FinanzNachrichten
Acticor Biotech: CORRECTING and REPLACING: Acticor Biotech Publishes Its Half-year Financial Results for 2024
Oct 16, 2024
FinanzNachrichten
Acticor Biotech: Acticor Biotech: Extension of the Call for Tenders With a View to a Restructuring Plan or Sale Under the Receivership Procedure
Jul 18, 2024
MarketScreener
Acticor Biotech: Acticor Biotech: Half-year Report on the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux
Jul 10, 2024
MarketScreener
Acticor Biotech: Acticor: operations financed through to September
Jul 09, 2024
MarketScreener
Acticor Biotech: Acticor Biotech SAS : Inside Information / News release on accounts, results
Jun 04, 2024
MarketScreener
Acticor Biotech: Acticor: hopes revived in stroke, share price rises
Acticor Biotech Competitors
1
2
3
4
5
6
7
8
9
10